Correlation Between BioSig Technologies, and Accsys Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Accsys Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Accsys Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioSig Technologies, Common and Accsys Technologies PLC, you can compare the effects of market volatilities on BioSig Technologies, and Accsys Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Accsys Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Accsys Technologies.

Diversification Opportunities for BioSig Technologies, and Accsys Technologies

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioSig and Accsys is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Accsys Technologies PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accsys Technologies PLC and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Accsys Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accsys Technologies PLC has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Accsys Technologies go up and down completely randomly.

Pair Corralation between BioSig Technologies, and Accsys Technologies

Given the investment horizon of 90 days BioSig Technologies, Common is expected to generate 5.03 times more return on investment than Accsys Technologies. However, BioSig Technologies, is 5.03 times more volatile than Accsys Technologies PLC. It trades about 0.42 of its potential returns per unit of risk. Accsys Technologies PLC is currently generating about -0.21 per unit of risk. If you would invest  82.00  in BioSig Technologies, Common on August 25, 2024 and sell it today you would earn a total of  111.00  from holding BioSig Technologies, Common or generate 135.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BioSig Technologies, Common  vs.  Accsys Technologies PLC

 Performance 
       Timeline  
BioSig Technologies, 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BioSig Technologies, Common are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, BioSig Technologies, displayed solid returns over the last few months and may actually be approaching a breakup point.
Accsys Technologies PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accsys Technologies PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

BioSig Technologies, and Accsys Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioSig Technologies, and Accsys Technologies

The main advantage of trading using opposite BioSig Technologies, and Accsys Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Accsys Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accsys Technologies will offset losses from the drop in Accsys Technologies' long position.
The idea behind BioSig Technologies, Common and Accsys Technologies PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance